Good Deed Turns Sour

Photo by Annie Spratt on Unsplash


*Kazakhstan, which supplies 40% of the uranium the world uses now, has entered a state of emergency after the govt was ousted. It is likely that uranium mining will be hit with strikes. Our Cameco CCJ which produces its uranium in Canada and the US has risen 4% again today, after the same rise Tuesday. The president resigned after his house was burned down by striking miners.

*Another gainer was Brazilian VALE, which we sold too soon.


*Another mystery sale by BAE Systems BAESY of Britain, $137 mn for life cycle sustainment of the US Navy's C51SR systems.

*GE, a golden oldie in my portfolio, has been upgraded to buy. 


*Rain Therapeutics RAIN, recently listed on Q, will do cancer trials with Roche's sub Genentech using tecentriq from the Swiss group and its own oral mouse double minute 2 milademetan. The patients in the phase I trial have lost their cyclin-dependent kinase 2A inhibitor and have wild-type p53. To begin in Q2, the trial may add other tumor types. Roche is providing the tecentriq.

*TEVA was upgraded to buy and rose 2.5% today, hitting $8.6/sh.

*Problems in delivery of its insulin took down Danish Novo Nordisk. It was upgraded to buy by Danske Bank today. NVO.


*Another oldy, American Express, also rose. AXP.

*Standard Life/Aberdeen (SLFPY, sold) was upgraded today and traded at GBX 2.46.


*Greencore, maker of ready meals, which I sold at the start of the covid-19 outbreak, is now back in play because British and Irish will be buying ready meals to make it easier for the family chef. GNCGF.


*Qualcomm, of which my donation is still not acknowledged by Radcliffe, today rose nearly 3% after its CEO said every company wants to have its own direct like to QCOM


How did you like this article? Let us know so we can better customize your reading experience.